For over 100 years, the American Cancer Society (ACS) has worked relentlessly to save lives and create a world with less cancer. Together with millions of our supporters worldwide, we help people stay well and get well, find cures, and fight back against cancer. To learn more, or for assistance, visit cancer.org or call 1.800.227.2345 anytime of the day or night.
Cancer Support Community is an international non-profit dedicated to providing support, education and hope to people affected by cancer. To ensure no one has to face cancer alone, these support services are available through a network of professionally led community-based centers, hospitals, community oncology practices and other non-profits, as well as online.
Imerman Angels, celebrating its 10-year anniversary in 2016, is the leading one-on-one cancer support community. It carefully matches cancer fighters, survivors and caregivers with a Mentor Angel – a volunteer who has gone through the same experience. These one-on-one relationships inspire hope and offer the chance to ask personal questions and receive support from someone who is intimately familiar with the experience. The service is absolutely free and helps anyone touched by any type of cancer, at any cancer stage level, at any age, living anywhere in the world. Imerman Angels is a federally registered 501(c)(3) not-for-profit organization.
The Ovarian Cancer National Alliance is the foremost advocate for women with ovarian cancer in the United States. To advance the interests of women with ovarian cancer, the organization advocates at a national level for increases in research funding for the development of an early detection test, improved health care practices, and life-saving treatment protocols.
Sharsheret, Hebrew for “chain”, is a national not-for-profit organization supporting young women and their families, of all Jewish backgrounds, facing breast cancer. Our mission is to offer a community of support to women diagnosed with breast cancer or at increased genetic risk, by fostering culturally-relevant individualized connections with networks of peers, health professionals, and related resources.
Cancer League of Colorado was established more than 40 years ago to raise money for cancer research and patient care in Colorado.
Over that time, we have awarded more than $10 million in grants for cancer-related service programs and research. Research funded by Cancer League has led to groundbreaking discoveries that have advanced the pursuit of our mission to secure the ultimate cure for or control of cancer.
The Tappan Foundation is a private family foundation that was started in 2004 by the late David S Tappan III with a mission of enabling and encouraging family members to get involved with non-profit causes that they are passionate about to give back to their local communities.
The George Karl Foundation is a catalyst of change, bringing together powerful partners to improve the cancer journey, beginning with educating people about cancer prevention to navigating the patient through treatments and ultimately to living healthy after surviving cancer.
Published quarterly by the American Association for Cancer Research, Cancer Today magazine empowers patients, survivors and caregivers with reliable, reader-friendly reporting on the latest advances in cancer research; insider looks at people driving progress against cancer; guidance on being an active partner in one’s treatment; candid stories about how people are dealing with the disease; and examinations of efforts to overcome obstacles to quality cancer care and quality of life.
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Astellas Pharma US, Inc. is committed to providing patients, customers, community and employees with a bright future by changing tomorrow. Our commitment is made possible because we are a different kind of pharmaceutical company. This is apparent not only in what we do, but how we do it.
Boehringer Ingelheim’s oncology research is driven by a passion to advance clinical practice and a determination to improve the lives of patients who are battling cancer . Through our own scientific innovation and partnerships, we are focused on discovering and providing novel best-in-class, breakthrough cancer medications that fit the needs of patients, caregivers and healthcare professionals. We have a clear strategy to become a leader in the field of lung cancer. Boehringer Ingelheim has successfully launched two products globally for NSCLC that have been widely adopted and established as valuable additions to current clinical practice. Continuous insights and learnings from research and development are key parts of innovation and our way forward to advance clinical practice in lung cancer and other cancer types.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
Eisai continues to grow its commitment to oncology—in research and clinical development, in approved treatments for cancer and supportive care, and in enhanced manufacturing capabilities. Eisai has a diverse in-house pipeline of oncology compounds in development and several more about to begin clinical trials.
Genentech is committed to being a strong corporate citizen by harnessing our unique resources, both financial and human, to contribute to the best interests of patients, the medical profession, our employees and our communities. Genentech supports a wide variety of organizations and initiatives through our corporate giving programs.
Genomic Health, a global health company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop clinically-validated molecular diagnostics. Determination that a test is accurate in determining the presence of, or predicting the risk for, a health condition or phenotype, including determination of sensitivity, specificity and positive and negative predictive values. which provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions.
Helsinn is a family run, privately owned pharmaceutical group headquartered in Lugano, Switzerland, focused on building quality cancer care with a large portfolio of products. Helsinn combines its heritage as a specialist in the in-licensing of new chemical entities with commercial, regulatory and research and development expertise to bring to market the highest quality pharmaceuticals, medical devices and nutritional supplement products in order to achieve our goal – to build better todays for people with cancer.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas.
Pfizer Oncology is committed to the discovery,investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline of biologics and small molecules, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers. By working collaboratively with academic institutions, individual researchers,cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, to deliver the right drug for each patient at the right time.
The Shortline Auto Group has supported dozens of non-profit community efforts during almost 30 years as a family-owned business in the Denver area. From cancer patient support to kids at risk to providing meals for senior citizens, we are honored to give a hand to the good folks who work tirelessly every day to make a difference both in our communities and in our lives. We believe our community is important and want to give back. MyLifeLine.org has touched our lives so to give back makes us feel complete. If you’d like to find out how you can help, visit shortlineonline.com and click on the "love our community" button.
Founded in 1968, Subaru of America, Inc. (SOA) is the U.S. Sales and Marketing subsidiary of Fuji Heavy Industries (FHI) of Japan and is responsible for the distribution, marketing, sales and service of Subaru vehicles in the United States.
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
RMCC is Colorado’s largest and most comprehensive provider of cancer care with 20 locations and more than 55 physicians throughout the state.